ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

HHS Forms Rural Task Force To Study, Improve Programs.

July 27, 2001

NCI-Approved Clinical Trials Listed For January

January 28, 2005

Adjuvant BC Therapy Is Topic Of NIH Consensus Conference.

January 28, 2000

Human Embryo Panel Defines Acceptable Research For Funding

September 30, 1994

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983